Article Details

Can BMYs Neuroscience Portfolio Help to Diversify Its Business? - Nasdaq

Retrieved on: 2025-10-08 16:15:08

Tags for this article:

Click the tags to see associated articles and topics

Can BMYs Neuroscience Portfolio Help to Diversify Its Business? - Nasdaq. View article details on hiswai:

Excerpt

BMY's neuroscience pipeline also includes candidates for neurodegenerative diseases (BMS-986495) and other candidates for multiple sclerosis, and mood ...

Article found on: www.nasdaq.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo